HAVCR2 and neoplasm: TIGIT (Figures 7C, D) and TIM-3 (Figures 8C, G, I) inhibitory receptors were specifically increased in TIL and not in NIL CD4 and CD8 T cells, suggesting that the tumor microenvironment plays a crucial role in inhibiting tumor-specific T-cell responses.